ANO5 Gene Miyoshi Muscular Dystrophy Type 3 Genetic Test
Cost: AED 4400.0
Symptoms and Diagnosis
Miyoshi muscular dystrophy type 3, also known as limb-girdle muscular dystrophy type 2L, is a rare genetic disorder characterized by progressive muscle weakness and atrophy primarily in the lower limbs. To diagnose this condition, a genetic test called ANO5 Gene Miyoshi Muscular Dystrophy Type 3 Genetic Test can be performed.
Test Details
The ANO5 gene is associated with Miyoshi muscular dystrophy type 3. The ANO5 Gene Miyoshi Muscular Dystrophy Type 3 Genetic Test utilizes NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously. This test can help identify mutations or variations in the ANO5 gene that may be responsible for the condition.
Components and Price
- Test Name: ANO5 Gene Miyoshi Muscular Dystrophy Type 3 Genetic Test
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
The report will be delivered within 3 to 4 weeks after the sample is received.
Test Type and Department
Test Type: Neurological Disorders
Test Department: Genetics
Pre Test Information
Prior to the test, the patient should provide their clinical history. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with ANO5 Gene Miyoshi Muscular Dystrophy Type 3.
Doctor and Method
Doctor: Neurologist
Method: NGS Technology
Importance of Genetic Testing
Genetic testing for ANO5 Gene Miyoshi Muscular Dystrophy Type 3 should be conducted and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors. They can provide appropriate guidance and support based on the test results. This type of genetic test can confirm a diagnosis, guide treatment decisions, and provide genetic counseling to affected individuals and their families. It can also be used for carrier testing in individuals with a family history of the condition.
| Test Name | ANO5 Gene Miyoshi muscular dystrophy type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ANO5 Gene Miyoshi muscular dystrophy type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ANO5 Gene Miyoshi muscular dystrophy type 3 |
| Test Details |
The ANO5 gene is associated with Miyoshi muscular dystrophy type 3, also known as limb-girdle muscular dystrophy type 2L. This is a rare genetic disorder characterized by progressive muscle weakness and atrophy primarily in the lower limbs. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the case of ANO5 gene testing, NGS can help identify mutations or variations in the ANO5 gene that may be responsible for Miyoshi muscular dystrophy type 3. This type of genetic test can be helpful in confirming a diagnosis, guiding treatment decisions, and providing genetic counseling to affected individuals and their families. It can also be used for carrier testing in individuals with a family history of the condition. It’s important to note that genetic testing should be conducted and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support based on the results. |
